We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Two Immunotherapies Converted Into Single Therapy for Certain Blood Cancers

News   Jul 24, 2020 | Original story from Washington University School of Medicine in St. Louis

 
Two Immunotherapies Converted Into Single Therapy for Certain Blood Cancers

Researchers at Washington University School of Medicine in St. Louis have combined two types of immunotherapy into a single treatment that may be more effective and possibly safer than current immunotherapies for blood cancers. Shown is a type of immune cell called a memory-like natural killer cell (right) attacking a leukemia cell (left). In the new study, the researchers modified the natural killer cells to help them find the leukemia cells more effectively. Credit: Julia Wagner

 
 
Advertisement
 

RELATED ARTICLES

Bacterial Enzymes Hijacked To Create Complex Molecules Usually Made by Plants

News

Chemists at Scripps Research have efficiently created three families of complex, oxygen-containing molecules that are normally obtainable only from plants.

READ MORE

MS Drug Blocks HIV Infection and Transmission in Human Immune Cells

News

Fingolimod, an FDA-approved immunosuppressive drug used to treat multiple sclerosis, may be used to block HIV infection and reduce the latent reservoir.

READ MORE

The Microbiome’s Role in Attacking Cancerous Tumors

News

Researchers have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE